+499.5%
MRNA vs GH
+169.0%
+330.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.2% | -2.5% | -2.3% |
| 7D | +5.5% | -0.1% | +5.5% | +5.6% |
| 30D | +158.7% | -1.1% | +159.8% | +160.6% |
| 3M | +182.1% | +21.3% | +160.8% | +163.9% |
| 6M | +151.8% | +73.5% | +78.3% | +105.7% |
| YTD | +393.6% | +58.0% | +335.5% | +312.9% |
| 1Y | +499.5% | +163.1% | +336.4% | +305.6% |
| All | +499.5% | +169.0% | +330.4% | +305.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GH.
Daily Out/Under-Performance
Portfolio return minus GH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling